Risk Assessment in Neonatal Early Onset Sepsis

Seminars in Perinatology

Volumn 36, Issue 6, 2012, Pages 408-415

  Mukhopadhyay, Sagori ^a,c   Puopolo, Karen M ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Early onset sepsis; Group B Streptococcus; Neonatal infection; Neonatal risk calculator; Risk assessment

Indexed keywords

ANTIBIOTIC AGENT;

ACUTE PHASE RESPONSE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; CHORIOAMNIONITIS; DISEASE DURATION; DISEASE SEVERITY; GESTATIONAL AGE; HIGH RISK INFANT; HUMAN; INCIDENCE; INFECTION RISK; INTRAPARTUM CARE; LEUKOCYTE COUNT; MEMBRANE RUPTURE; MOTHER CHILD RELATION; NEWBORN SEPSIS; PATHOGENESIS; PERINATAL DRUG EXPOSURE; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; STREPTOCOCCUS AGALACTIAE; VERY LOW BIRTH WEIGHT;

AGE OF ONSET; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ASYMPTOMATIC DISEASES; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MODELS, STATISTICAL; PERINATAL CARE; POLICY MAKING; PREGNANCY; RISK ASSESSMENT; RISK FACTORS; SEPSIS; SEVERITY OF ILLNESS INDEX; STREPTOCOCCUS AGALACTIAE;

EID: 84870210333     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2012.06.002     Document Type: Review

References (62)

1. Prevention of perinatal group B streptococcal disease: A public health perspective. Centers for Disease Control and Prevention. MMWR Recomm Rep 1996, 45(RR-7):1-24.
2. Schuchat A., Zywicki S.S., Dinsmoor M.J., et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: A multicenter case-control study. Pediatrics 2000, 105:21-26.
3. Bizzarro M.J., Raskind C., Baltimore R.S., et al. Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics 2005, 116:595-602.
4. Puopolo K.M., Eichenwald E.C. No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years. Pediatrics 2010, 125:e1031-e1038.
5. Weston E.J., Pondo T., Lewis M.M., et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J 2011, 30:937-941.
6. Stoll B.J., Hansen N.I., Sánchez P.J., et al. Early onset neonatal sepsis: The burden of group B streptococcal and E. coli disease continues. Pediatrics 2011, 127:817-826.
7. Verani J.R., McGee L., Schrag S.J. Prevention of perinatal group B streptococcal disease-Revised guidelines from CDC. MMWR Recomm Rep 2010, 59(RR-10):1-36. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC).
8. Hyde T.B., Hilger T.M., Reingold A., et al. Trends in incidence and antimicrobial resistance of early-onset sepsis: Population-based surveillance in San Francisco and Atlanta. Pediatrics 2002, 110:690-695.
9. Stoll B.J., Hansen N.I., Higgins R.D., et al. Very low birth weight preterm infants with early onset neonatal sepsis: The predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr Infect Dis J 2005, 24:635-639.
10. Phares C.R., Lynfield R., Farley M.M., et al. Epidemiology of Invasive Group B streptococcal disease in the United States, 1999-2005. JAMA 2008, 299:2056-2065.
11. Benirschke K. Routes and types of infection in the fetus and the newborn. AMA J Dis Child 1960, 99:714-721.
12. Blanc W.A. Pathways of fetal and early neonatal infection. Viral placentitis, bacterial and fungal chorioamnionitis. J Pediatr 1961, 59:473-496.
13. Stoll B.J., Hansen N.I., Bell E.F., et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010, 126:443-456.
14. Cohen-Wolkowiez M., Moran C., Benjamin D.K., et al. Early and late onset sepsis in late preterm infants. Pediatr Infect Dis J 2009, 28:1052-1056.
15. Puopolo K.M., Draper D., Wi S., et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics 2011, 128:e1155-e1163.
16. Benitz W.E., Gould J.B., Druzin M.L. Risk factors for early-onset group B streptococcal sepsis: Estimation of odds ratios by critical literature review. Pediatrics 1999, 103:e77.
17. Wynn J.L., Levy O. Role of innate host defenses in susceptibility to early-onset neonatal sepsis. Clin Perinatol 2010, 37:307-337.
18. Fishman S.G., Gelber S.E. Evidence for the clinical management of chorioamnionitis. Semin Fetal Neonatal Med 2012, 17:46-50.
19. Alexander J.M., Gilstrap L.C., Cox S.M., et al. Clinical chorioamnionitis and the prognosis for very low birth weight infants. Obstet Gynecol 1998, 91:725-729.
20. Alexander J.M., McIntire D.M., Leveno K.J. Chorioamnionitis and the prognosis for term infants. Obstet Gynecol 1999, 94:274-278.
21. Escobar G.J., Li D.K., Armstrong M.A., et al. Neonatal sepsis workups in infants ≥2000 grams at birth: A population-based study. Pediatrics 2000, 106:256-263.
22. Boyer K.M., Gadzala C.A., Burd L.I., et al. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. J Infect Dis 1983, 148:795-801.
23. Schuchat A., Zywicki S.S., Dinsmoor M.J., et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: A multicenter case-control study. Pediatrics 2000, 105:21-26.
24. Schrag S.J., Hadler J.L., Arnold K.E., et al. Risk factors for invasive, early-onset Escherichia coli infections in the era of widespread intrapartum antibiotic use. Pediatrics 2006, 118:570-576.
25. Baker C.J., Barrett F.F. Transmission of group B streptococci among parturient women and their neonates. J Pediatr 1973, 83:919-925.
26. Stoll B.J., Hansen N., Fanaroff A.A., et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002, 347:240-247.
27. Meyn L.A., Moore D.M., Hillier S.L., et al. Association of sexual activity with colonization and vaginal acquisition of group B Streptococcus in nonpregnant women. Am J Epidemiol 2002, 155:949-957.
28. Baker C.J., Kasper D.L. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976, 294:753-756.
29. Schrag S., Gorwitz R., Fultz-Butts K., et al. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002, 51(RR-11):1-22.
30. Boyer K.M., Gadzala C.A., Kelly P.D., et al. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. J Infect Dis 1983, 148:810-816.
31. Boyer K.M., Gotoff S.P. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986, 314:1665-1669.
32. Puopolo K.M., Madoff L.C., Eichenwald E.C. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 2005, 115:1240-1246.
33. Van Dyke M.K., Phares C.R., Lynfield R., et al. Evaluation of universal antenatal screening for group B Streptococcus. N Engl J Med 2009, 360:2626-2636.
34. Schuchat A., Oxtoby M., Cochi S., et al. Population-based risk factors for neonatal group B streptococcal disease: Results of a cohort study in metropolitan Atlanta. J Infect Dis 1990, 162:672-677.
35. Perinatal group B streptococcal disease after universal screening recommendations-United States, 2003-2005. MMWR Morb Mortal Wkly Rep 2007, 56:701-705. Centers for Disease Control and Prevention (CDC).
36. Schrag S.J., Zell E.R., Lynfield R., et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002, 347:233-239.
37. Johnson C.E., Whitwell J.K., Pethe K., et al. Term newborns who are at risk for sepsis: Are lumbar punctures necessary?. Pediatrics 1997, 99:e10-e14.
38. Mukhopadhyay S., Eichenwald E.C., Puopolo K.M. Neonatal early-onset sepsis evaluations among well-appearing infants: projected impact of changes in CDC GBS guidelines. J Perinatol 2012, in press.
39. Manroe B.L., Weinberg A.G., Rosenfeld C.R., et al. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 1979, 95:89-98.
40. Ottolini M.C., Lundgren K., Mirkinson L.J., et al. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J 2003, 22:430-434.
41. Jackson G.L., Engle W.D., Sendelbach D.M., et al. Are complete blood cell counts useful in the evaluation of asymptomatic neonates exposed to suspected chorioamnionitis?. Pediatrics 2004, 113:1173-1180.
42. Schmutz N., Henry E., Jopling J., et al. Expected ranges for blood neutrophil concentrations of neonates: The Manroe and Mouzinho charts revisited. J Perinatol 2008, 28:275-281.
43. Newman T.B., Puopolo K.M., Wi S., et al. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 2010, 126:903-909.
44. Sabel K.G., Wadsworth C. C-reactive protein (CRP) in early diagnosis of neonatal septicemia. Acta Paediatr Scand 1979, 68:825-831.
45. Benitz W.E., Han M.Y., Madan A., et al. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 1998, 102:e41.
46. Enguix A., Rey C., Concha A., et al. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med 2001, 27:211-215.
47. Vouloumanou E.K., Plessa E., Karageorgopoulos D.E., et al. Serum procalcitonin as a diagnostic marker for neonatal sepsis: A systematic review and meta-analysis. Intensive Care Med 2011, 37:747-762.
48. Benitz W.E. Adjunct laboratory tests in the diagnosis of early-onset neonatal sepsis. Clin Perinatol 2010, 37:421-438.
49. Kocabaş E., Sarikçioǧlu A., Aksaray N., et al. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis. Turk J Pediatr 2007, 49:7-20.
50. Cancelier A.C., Petronilho F., Reinke A., et al. Inflammatory and oxidative parameters in cord blood as diagnostic of early-onset neonatal sepsis: A case-control study. Pediatr Crit Care Med 2009, 10:467-471.
51. Buhimschi I.A., Buhimschi C.S. The role of proteomics in the diagnosis of chorioamnionitis and early-onset neonatal sepsis. Clin Perinatol 2010, 37:355-374.
52. Clark R.H., Bloom B.T., Spitzer A.R., et al. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics 2006, 117:67-74.
53. Cotten C.M., Taylor S., Stoll B., et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009, 123:58-66.
54. Dutta S., Reddy R., Sheikh S., et al. Intrapartum antibiotics and risk factors for early onset sepsis. Arch Dis Child Fetal Neonatal Ed 2010, 95:F99-F103.
55. Bromberger P., Lawrence J.M., Braun D., et al. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics 2000, 106:244-250.
56. Moore M.R., Schrag S.J., Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 2003, 3:201-213.
57. Cotten C.M., McDonald S., Stoll B., et al. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 2006, 118:717-722.
58. Kuppala V.S., Meinzen-Derr J., Morrow A.L., et al. Prolonged initial Empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 2011, 159:720-725.
59. Alexander V.N., Northrup V., Bizzarro M.J. Antibiotic exposure in the newborn Intensive Care Unit and the risk of necrotizing enterocolitis. J Pediatr 2011, 159:392-397.
60. Alm B., Erdes L., Möllborg P., et al. Neonatal antibiotic treatment is a risk factor for early wheezing. Pediatrics 2008, 121:697-702.
61. Goksör E., Alm B., Thengilsdottir H., et al. Preschool wheeze-Impact of early fish introduction and neonatal antibiotics. Acta Paediatr 2011, 100:1561-1566.
62. Murgas Torrazza R., Neu J. The developing intestinal microbiome and its relationship to health and disease in the neonate. J Perinatol 2011, 31(suppl 1):S29-S34.